Estadisticas : DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)

Hidalgo-Tenorio, Carmen
Visitas:274

207

34

10

8

6

3

2

1

1

1

1

Descargas: 91